1 Market Overview

1.1 Product Overview and Scope of Tuberculosis Diagnosis and Treatment

1.2 Classification of Tuberculosis Diagnosis and Treatment by Type

1.2.1 Overview: Global Tuberculosis Diagnosis and Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type in 2021

1.2.3 Laboratory Testing

1.2.4 Nucleic Acid Tests

1.2.5 Mantoux Test

1.2.6 Radiography

1.2.7 Drug Susceptibility Test

1.3 Global Tuberculosis Diagnosis and Treatment Market by Application

1.3.1 Overview: Global Tuberculosis Diagnosis and Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Government organizations

1.3.4 Individual

1.4 Global Tuberculosis Diagnosis and Treatment Market Size & Forecast

1.5 Global Tuberculosis Diagnosis and Treatment Market Size and Forecast by Region

1.5.1 Global Tuberculosis Diagnosis and Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Tuberculosis Diagnosis and Treatment Market Size by Region, (2017-2022)

1.5.3 North America Tuberculosis Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Tuberculosis Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Tuberculosis Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Tuberculosis Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tuberculosis Diagnosis and Treatment Market Drivers

1.6.2 Tuberculosis Diagnosis and Treatment Market Restraints

1.6.3 Tuberculosis Diagnosis and Treatment Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Product and Solutions

2.1.4 Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Akonni Biosystems

2.2.1 Akonni Biosystems Details

2.2.2 Akonni Biosystems Major Business

2.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Product and Solutions

2.2.4 Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Akonni Biosystems Recent Developments and Future Plans

2.3 Thermo Fisher Scientific

2.3.1 Thermo Fisher Scientific Details

2.3.2 Thermo Fisher Scientific Major Business

2.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product and Solutions

2.3.4 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.4 BD

2.4.1 BD Details

2.4.2 BD Major Business

2.4.3 BD Tuberculosis Diagnosis and Treatment Product and Solutions

2.4.4 BD Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 BD Recent Developments and Future Plans

2.5 Bio-Synth

2.5.1 Bio-Synth Details

2.5.2 Bio-Synth Major Business

2.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Product and Solutions

2.5.4 Bio-Synth Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Bio-Synth Recent Developments and Future Plans

2.6 bioMérieux

2.6.1 bioMérieux Details

2.6.2 bioMérieux Major Business

2.6.3 bioMérieux Tuberculosis Diagnosis and Treatment Product and Solutions

2.6.4 bioMérieux Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 bioMérieux Recent Developments and Future Plans

2.7 Cepheid

2.7.1 Cepheid Details

2.7.2 Cepheid Major Business

2.7.3 Cepheid Tuberculosis Diagnosis and Treatment Product and Solutions

2.7.4 Cepheid Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Cepheid Recent Developments and Future Plans

2.8 Eiken Chemical

2.8.1 Eiken Chemical Details

2.8.2 Eiken Chemical Major Business

2.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Product and Solutions

2.8.4 Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eiken Chemical Recent Developments and Future Plans

2.9 Epistem

2.9.1 Epistem Details

2.9.2 Epistem Major Business

2.9.3 Epistem Tuberculosis Diagnosis and Treatment Product and Solutions

2.9.4 Epistem Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Epistem Recent Developments and Future Plans

2.10 Roche

2.10.1 Roche Details

2.10.2 Roche Major Business

2.10.3 Roche Tuberculosis Diagnosis and Treatment Product and Solutions

2.10.4 Roche Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Roche Recent Developments and Future Plans

2.11 GSK

2.11.1 GSK Details

2.11.2 GSK Major Business

2.11.3 GSK Tuberculosis Diagnosis and Treatment Product and Solutions

2.11.4 GSK Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 GSK Recent Developments and Future Plans

2.12 Hain Lifesciences

2.12.1 Hain Lifesciences Details

2.12.2 Hain Lifesciences Major Business

2.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Product and Solutions

2.12.4 Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Hain Lifesciences Recent Developments and Future Plans

2.13 Hologic

2.13.1 Hologic Details

2.13.2 Hologic Major Business

2.13.3 Hologic Tuberculosis Diagnosis and Treatment Product and Solutions

2.13.4 Hologic Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Hologic Recent Developments and Future Plans

2.14 Labatec

2.14.1 Labatec Details

2.14.2 Labatec Major Business

2.14.3 Labatec Tuberculosis Diagnosis and Treatment Product and Solutions

2.14.4 Labatec Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Labatec Recent Developments and Future Plans

2.15 Lupin

2.15.1 Lupin Details

2.15.2 Lupin Major Business

2.15.3 Lupin Tuberculosis Diagnosis and Treatment Product and Solutions

2.15.4 Lupin Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Lupin Recent Developments and Future Plans

2.16 Otsuka Novel Products

2.16.1 Otsuka Novel Products Details

2.16.2 Otsuka Novel Products Major Business

2.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product and Solutions

2.16.4 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Otsuka Novel Products Recent Developments and Future Plans

2.17 QIAGEN

2.17.1 QIAGEN Details

2.17.2 QIAGEN Major Business

2.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Product and Solutions

2.17.4 QIAGEN Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 QIAGEN Recent Developments and Future Plans

2.18 Sandoz

2.18.1 Sandoz Details

2.18.2 Sandoz Major Business

2.18.3 Sandoz Tuberculosis Diagnosis and Treatment Product and Solutions

2.18.4 Sandoz Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Sandoz Recent Developments and Future Plans

2.19 Sanofi

2.19.1 Sanofi Details

2.19.2 Sanofi Major Business

2.19.3 Sanofi Tuberculosis Diagnosis and Treatment Product and Solutions

2.19.4 Sanofi Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Tuberculosis Diagnosis and Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Tuberculosis Diagnosis and Treatment Players Market Share in 2021

3.2.2 Top 10 Tuberculosis Diagnosis and Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Tuberculosis Diagnosis and Treatment Players Head Office, Products and Services Provided

3.4 Tuberculosis Diagnosis and Treatment Mergers & Acquisitions

3.5 Tuberculosis Diagnosis and Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Tuberculosis Diagnosis and Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2028)

6.2 North America Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2028)

6.3 North America Tuberculosis Diagnosis and Treatment Market Size by Country

6.3.1 North America Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2028)

6.3.2 United States Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2028)

7.2 Europe Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2028)

7.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Country

7.3.1 Europe Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2028)

7.3.2 Germany Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.3 France Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region

8.3.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Region (2017-2028)

8.3.2 China Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.5 India Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2028)

9.2 South America Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2028)

9.3 South America Tuberculosis Diagnosis and Treatment Market Size by Country

9.3.1 South America Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country

10.3.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Tuberculosis Diagnosis and Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tuberculosis Diagnosis and Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Tuberculosis Diagnosis and Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Tuberculosis Diagnosis and Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Tuberculosis Diagnosis and Treatment Product and Solutions

Table 9. Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Akonni Biosystems Corporate Information, Head Office, and Major Competitors

Table 11. Akonni Biosystems Major Business

Table 12. Akonni Biosystems Tuberculosis Diagnosis and Treatment Product and Solutions

Table 13. Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 15. Thermo Fisher Scientific Major Business

Table 16. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product and Solutions

Table 17. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. BD Corporate Information, Head Office, and Major Competitors

Table 19. BD Major Business

Table 20. BD Tuberculosis Diagnosis and Treatment Product and Solutions

Table 21. BD Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Bio-Synth Corporate Information, Head Office, and Major Competitors

Table 23. Bio-Synth Major Business

Table 24. Bio-Synth Tuberculosis Diagnosis and Treatment Product and Solutions

Table 25. Bio-Synth Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. bioMérieux Corporate Information, Head Office, and Major Competitors

Table 27. bioMérieux Major Business

Table 28. bioMérieux Tuberculosis Diagnosis and Treatment Product and Solutions

Table 29. bioMérieux Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Cepheid Corporate Information, Head Office, and Major Competitors

Table 31. Cepheid Major Business

Table 32. Cepheid Tuberculosis Diagnosis and Treatment Product and Solutions

Table 33. Cepheid Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eiken Chemical Corporate Information, Head Office, and Major Competitors

Table 35. Eiken Chemical Major Business

Table 36. Eiken Chemical Tuberculosis Diagnosis and Treatment Product and Solutions

Table 37. Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Epistem Corporate Information, Head Office, and Major Competitors

Table 39. Epistem Major Business

Table 40. Epistem Tuberculosis Diagnosis and Treatment Product and Solutions

Table 41. Epistem Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Roche Corporate Information, Head Office, and Major Competitors

Table 43. Roche Major Business

Table 44. Roche Tuberculosis Diagnosis and Treatment Product and Solutions

Table 45. Roche Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. GSK Corporate Information, Head Office, and Major Competitors

Table 47. GSK Major Business

Table 48. GSK Tuberculosis Diagnosis and Treatment Product and Solutions

Table 49. GSK Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Hain Lifesciences Corporate Information, Head Office, and Major Competitors

Table 51. Hain Lifesciences Major Business

Table 52. Hain Lifesciences Tuberculosis Diagnosis and Treatment Product and Solutions

Table 53. Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Hologic Corporate Information, Head Office, and Major Competitors

Table 55. Hologic Major Business

Table 56. Hologic Tuberculosis Diagnosis and Treatment Product and Solutions

Table 57. Hologic Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Labatec Corporate Information, Head Office, and Major Competitors

Table 59. Labatec Major Business

Table 60. Labatec Tuberculosis Diagnosis and Treatment Product and Solutions

Table 61. Labatec Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Lupin Corporate Information, Head Office, and Major Competitors

Table 63. Lupin Major Business

Table 64. Lupin Tuberculosis Diagnosis and Treatment Product and Solutions

Table 65. Lupin Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Otsuka Novel Products Corporate Information, Head Office, and Major Competitors

Table 67. Otsuka Novel Products Major Business

Table 68. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product and Solutions

Table 69. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. QIAGEN Corporate Information, Head Office, and Major Competitors

Table 71. QIAGEN Major Business

Table 72. QIAGEN Tuberculosis Diagnosis and Treatment Product and Solutions

Table 73. QIAGEN Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Sandoz Corporate Information, Head Office, and Major Competitors

Table 75. Sandoz Major Business

Table 76. Sandoz Tuberculosis Diagnosis and Treatment Product and Solutions

Table 77. Sandoz Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Sanofi Corporate Information, Head Office, and Major Competitors

Table 79. Sanofi Major Business

Table 80. Sanofi Tuberculosis Diagnosis and Treatment Product and Solutions

Table 81. Sanofi Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 83. Global Tuberculosis Diagnosis and Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 84. Breakdown of Tuberculosis Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Tuberculosis Diagnosis and Treatment Players Head Office, Products and Services Provided

Table 86. Tuberculosis Diagnosis and Treatment Mergers & Acquisitions in the Past Five Years

Table 87. Tuberculosis Diagnosis and Treatment New Entrants and Expansion Plans

Table 88. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) by Type (2017-2022)

Table 89. Global Tuberculosis Diagnosis and Treatment Revenue Share by Type (2017-2022)

Table 90. Global Tuberculosis Diagnosis and Treatment Revenue Forecast by Type (2023-2028)

Table 91. Global Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022)

Table 92. Global Tuberculosis Diagnosis and Treatment Revenue Forecast by Application (2023-2028)

Table 93. North America Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 94. North America Tuberculosis Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 95. North America Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 96. North America Tuberculosis Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 97. North America Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 98. North America Tuberculosis Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 99. Europe Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 100. Europe Tuberculosis Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 101. Europe Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 102. Europe Tuberculosis Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 103. Europe Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 104. Europe Tuberculosis Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 105. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 106. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 107. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 108. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 109. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Region (2017-2022) & (USD Million)

Table 110. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Region (2023-2028) & (USD Million)

Table 111. South America Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 112. South America Tuberculosis Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 113. South America Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 114. South America Tuberculosis Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 115. South America Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 116. South America Tuberculosis Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 117. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 118. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 119. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 120. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 121. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 122. Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Tuberculosis Diagnosis and Treatment Picture

Figure 2. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type in 2021

Figure 3. Laboratory Testing

Figure 4. Nucleic Acid Tests

Figure 5. Mantoux Test

Figure 6. Radiography

Figure 7. Drug Susceptibility Test

Figure 8. Tuberculosis Diagnosis and Treatment Revenue Market Share by Application in 2021

Figure 9. Hospitals Picture

Figure 10. Government organizations Picture

Figure 11. Individual Picture

Figure 12. Global Tuberculosis Diagnosis and Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Tuberculosis Diagnosis and Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Region (2017-2028)

Figure 15. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Region in 2021

Figure 16. North America Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Tuberculosis Diagnosis and Treatment Market Drivers

Figure 22. Tuberculosis Diagnosis and Treatment Market Restraints

Figure 23. Tuberculosis Diagnosis and Treatment Market Trends

Figure 24. Abbott Laboratories Recent Developments and Future Plans

Figure 25. Akonni Biosystems Recent Developments and Future Plans

Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 27. BD Recent Developments and Future Plans

Figure 28. Bio-Synth Recent Developments and Future Plans

Figure 29. bioMérieux Recent Developments and Future Plans

Figure 30. Cepheid Recent Developments and Future Plans

Figure 31. Eiken Chemical Recent Developments and Future Plans

Figure 32. Epistem Recent Developments and Future Plans

Figure 33. Roche Recent Developments and Future Plans

Figure 34. GSK Recent Developments and Future Plans

Figure 35. Hain Lifesciences Recent Developments and Future Plans

Figure 36. Hologic Recent Developments and Future Plans

Figure 37. Labatec Recent Developments and Future Plans

Figure 38. Lupin Recent Developments and Future Plans

Figure 39. Otsuka Novel Products Recent Developments and Future Plans

Figure 40. QIAGEN Recent Developments and Future Plans

Figure 41. Sandoz Recent Developments and Future Plans

Figure 42. Sanofi Recent Developments and Future Plans

Figure 43. Global Tuberculosis Diagnosis and Treatment Revenue Share by Players in 2021

Figure 44. Tuberculosis Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 45. Global Top 3 Players Tuberculosis Diagnosis and Treatment Revenue Market Share in 2021

Figure 46. Global Top 10 Players Tuberculosis Diagnosis and Treatment Revenue Market Share in 2021

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 48. Global Tuberculosis Diagnosis and Treatment Revenue Share by Type in 2021

Figure 49. Global Tuberculosis Diagnosis and Treatment Market Share Forecast by Type (2023-2028)

Figure 50. Global Tuberculosis Diagnosis and Treatment Revenue Share by Application in 2021

Figure 51. Global Tuberculosis Diagnosis and Treatment Market Share Forecast by Application (2023-2028)

Figure 52. North America Tuberculosis Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 53. North America Tuberculosis Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 54. North America Tuberculosis Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 55. United States Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Canada Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Mexico Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Europe Tuberculosis Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 59. Europe Tuberculosis Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 60. Europe Tuberculosis Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 61. Germany Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. France Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. United Kingdom Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Russia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Italy Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Asia-Pacific Tuberculosis Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 67. Asia-Pacific Tuberculosis Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 68. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Share by Region (2017-2028)

Figure 69. China Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Japan Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South Korea Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. India Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Southeast Asia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Australia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. South America Tuberculosis Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 76. South America Tuberculosis Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 77. South America Tuberculosis Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 78. Brazil Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Argentina Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Middle East and Africa Tuberculosis Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Tuberculosis Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 83. Turkey Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Saudi Arabia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. UAE Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source